Table 3 Travel behavior of travelling patients carrying HRMO at admission compared to not carrying HRMO at admission

Duration T < 1 month

105 (89.7)

7 (100)*

98 (89.1)*

Duration T 1–3 months

9 (7.7)

0 (0)

9 (8.2)

Duration T 3–6 months

2 (1.7)

0 (0)

2 (1.8)

Duration T 6–12 months

1 (0.9)

0 (0)

1 (0.9)

Travelling outside of Europe < 1y

30 (25.6)

4 (57.1)

26 (23.6)**

Travelling within Europe < 1y

87 (74.4)

3 (42.9)

84 (76.4)

Ice cream and pastry consumption (%)

64^c (56.1)

3^a (50)

61^b (56.5)

Meals at street food stalls (%)

10^a (8.6)

0 (0)

10^a (9.2)

Experienced vomiting during travel (%)

3^a (2.6)

0 (0)

3^a (2.8)

Experienced diarrhea during travel (%)

6^a (5.2)

1 (14.3)

5^a (4.6)

Admitted to hospital during travel (%)

8 (6.8)

0 (0)

8 (7.3)

Antibiotic use during travel (%)

6^b (5.2)

1 (14.3)

5^b (4.6)

Antacid use during travel (%)

22^c (19.3)

1^a (16.7)

21^b (19.4)

Used malaria prophylaxis during travel (%)

1^a (0.9)

0 (0)

1^a (0.9)